Amgen Suffers Surprise Blow as New Bone Density Safety
1 day ago · Amgen lost more than 7% of its value in trading on Tuesday after reports circulated that its highly anticipated obesity candidate MariTide could have negative effects on bone mineral density, raising concerns that the investigational therapy could aggravate the risk of fractures in patients. The bone marrow density (BMD) data were first spotted ...
Amgen speaks out about bone density concerns with obesity drug
17 hours ago · AMGN. Amgen has spoken out about concerns related to bone mineral density (BMD) loss with its obesity candidate after an analyst’s comment caused a $12bn market wipe. The company has tried to ...
Amgen dismisses bone density concerns related to its weight-loss …
1 day ago · The drugmaker's stock slumped 7% on Tuesday after analysts at Cantor Fitzgerald said their review of early-stage data on Amgen's MariTide showed a drop in bone mineral density, which can increase ...
Amgen Defends Its Investigational Monthly Weight Loss Injection …
1 day ago · Analysts referred to new public data from a phase one study, showing that the highest dose of MariTide (420 milligrams) was associated with around 4% decrease in bone mineral density over 12 weeks.
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
1 day ago · The Phase 1 study results do not suggest any bone safety concern or change our conviction in the promise of MariTide. We look forward to sharing the Phase 2 topline data later this year."
Amgen MariTide bone mineral density loss data ‘leaked,’ says …
3 days ago · Nov. 12, 2024, 01:30 PM. Cantor Fitzgerald tells investors that MariTide’s Phase 1 data includes “a big surprise” as the supplemental appendix file seems to show bone mineral density, or BMD ...
A scrap of data on Amgen's obesity drug MariTide wipes out …
2 days ago · Nov. 12, 2024. National Biotech Reporter. On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value. The data, spotted by an ...
Amgen Says No Link Between MariTide, Bone Density Loss
2 days ago · Resize. By Colin Kellaher. Amgen on Wednesday sought to allay concerns that its MariTide, investigational weight-loss shot could be linked to a loss of bone mineral density. Amgen shares fell more ...
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
1 day ago · "As previously stated, Amgen does not see an association between the administration of MariTide and bone mineral density changes. The Phase 1 study results do not suggest any bone safety concern ...
Amgen issues statement regarding MariTide Phase 1 data
1 day ago · Amgen (AMGN) issued the following statement on the MariTide Phase 1 data. “As previously stated, Amgen does not see an association between the administration of MariTide and bone mineral density ...
- Some results have been removed